Monoclonal antibodies work well in reducing COVID-19 related emergency department visits and hospitalizations when administered early to high-risk patients, a study demonstrates. If used under FDA guidelines, the researchers suggest, this treatment can ease the pandemic’s continuing burden on patients and on limited health care resources.
Click here for original story, Timely treatment with COVID-19 monoclonal antibodies can reduce hospitalizations, pandemic’s stress on health care systems
Source: ScienceDaily